Latest news with #PeterGoldstein
Yahoo
9 hours ago
- Business
- Yahoo
Clear Choice Headsets & Technology Reinforces its Commitment to the Public Safety Market as a Sponsor and Exhibitor at NENA 2025
Showcasing New, Innovative Solutions for the Dispatch Community Wheeling, Illinois--(Newsfile Corp. - June 18, 2025) - Clear Choice Headsets & Technology, a premier provider of trusted headsets and communication solutions for the public safety market, is excited to announce it is a Bronze Level Sponsor and first time exhibitor (booth 1018) at the 2025 NENA (National Emergency Number Association) Conference & Expo at the Long Beach Convention Center, June 21-26. At the booth, attendees can see the latest communication offerings from top tier equipment suppliers, such as Secure Headset Group (SHG), Jabra, Yealink, EPOS and Shokz. "Our presence at NENA demonstrates our continued dedication and long term commitment to the public safety market," declared Peter Goldstein, CEO of Clear Choice Headsets & Technology. "While other companies are exiting this space, we have been ramping up our efforts by expanding our team, relocating to a larger facility, and collaborating with partners to develop high-performing equipment that meets the ever-evolving critical demands of the 911 community." As the exclusive distributor of Secure Headset Group® products, two recently introduced cables will be on display in the Clear Choice Headsets booth (1018). - SHG S D145-PTT/AMP Push-To-Talk CableA six-wire amplifier cable that provides PL QD (quick disconnect) to a PJ7 2-prong adaptor with an in-line PTT (push-to-talk) button, which has been tested over one million cycles. To view an enhanced version of this graphic, please visit: - SHG S D145-PTT Push-To-Talk CableA commercial grade 6-wire cable that provides PL QD (quick disconnect) to a PJ7 2-prong adaptor with a PTT button tested over one million cycles. To view an enhanced version of this graphic, please visit: In addition to these new products, attendees can see and try on a wide variety of headsets that relieve ear fatigue, ensure all day comfort, and are trusted already by dispatch centers across the country. Mr. Goldstein, along with SHG CEO, Aaron Gitler, and other team members, will be onsite at NENA to connect with customers, and discuss their current and future communication needs. "We offer a complete product portfolio, including custom headsets that are designed specifically for the public safety community," stated Mr. Goldstein, "For nearly four decades, dispatchers have been trusting our headsets during life's most critical moments. We plan to continue and grow this partnership for many more years to come. We look forward to meeting with attendees at NENA." About Clear Choice Headsets & Technology Clear Choice Headsets & Technology is a premier provider of a wide variety of headsets, conferencing solutions, and accessories. It is the one stop shop for the best communications equipment, representing many of the leading brands in the industry. In addition, it is the exclusive distributor of headsets and accessories from Secure Headset Group® (SHG), formerly known as Starkey Headsets. For almost four decades, Clear Choice Headsets has been providing best-in-class customer experience. Customers have a single point of contact, resulting in lasting and trusted partnerships. Clear Choice Headsets offers accurate and fast product fulfillment with a large product inventory in its centrally located Midwest warehouse. For more information, please visit or follow Clear Choice on LinkedIn and Facebook. For more information or to schedule a one-on-one meeting during NENA 2025, please contact: Lynn Ventimiglia-Lobitlynn@ 847-269-1422 © 2025 Clear Choice Headsets & Technology, LLC. All rights reserved. To view the source version of this press release, please visit Inicia sesión para acceder a tu cartera de valores
Associated Press
04-04-2025
- Business
- Associated Press
IPO Summit 2025 to Empower Emerging Growth Companies at NASDAQ
NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / On April 15, 2025, the inaugural IPO Summit, hosted by renowned capital markets advisor Peter Goldstein of Exchange Listing LLC, will convene at NASDAQ in New York City. This premier event empowers small- and micro-cap founders, CEOs, and growth-stage companies with the strategic insights, actionable tools, and essential networks they need to excel in today's dynamic public markets. The inaugural IPO Summit will deliver high-impact programs featuring expert knowledge, real-time market data, and a dynamic community of trailblazing leaders. Attendees will collaborate directly with experts shaping the future of IPOs, gaining invaluable visibility and refining their IPO-readiness strategies. 'This summit is more than just another conference-it's an interactive accelerator for growth-stage companies looking to transition into public markets,' stated Peter Goldstein, CEO of Exchange Listing LLC and author of The Entrepreneur's IPO. Robust IPO Activity in 2025 The IPO landscape is experiencing remarkable growth in 2025. With 49 new filings and 36 offerings priced, IPO activity is up 63.6% compared to last year, and revenue growth is rising by 14%. Capital raised is projected to reach between $45-$50 billion by year-end, bolstered by renewed investor confidence and economic stability. A Unique Opportunity The summit provides essential insights on IPO readiness through SPACs, Regulation A+, or traditional IPO pathways. 'Public status significantly enhances liquidity, brand visibility, and credibility. It also strategically positions companies for stock-based mergers and acquisitions and flexible follow-on financing,' added Goldstein. Distinguished Speakers and Panelists This year's summit features influential speakers including: Key discussions will include navigating IPO readiness, mastering audits, underwriting dynamics, and strategic communication post-listing. Session 1: From Private to Public: Navigating the IPO Journey Session 2: Mastering the Audit Maze Session 3: Structuring Success Session 4: The Senior Exchange Blueprint Session 5: The Trading Playbook Session 6: Life After Listing Ending Keynote: Fireside Chat with Brad Bondi, Global Co-Chair of Investigations and White Collar Defense at Paul Hastings, LLP Event Details: Join the forefront of public market innovation and strategy at the IPO Summit 2025. For inquiries, contact: Michelle Almonte About Exchange Listing, LLC: Exchange Listing, LLC is a premier advisory firm specializing in guiding growth-oriented companies through the intricacies of listing on senior stock exchanges, such as NASDAQ and the NYSE. The firm offers comprehensive strategic services, including navigating complex IPO processes, audit preparation, regulatory compliance, and post-listing investor relations management. With a proven track record and deep industry expertise, Exchange Listing, LLC helps companies optimize their market value, attract the right investors, and ensure sustainable success long after going public.
Associated Press
29-01-2025
- Business
- Associated Press
Akelos Inc. Receives Chinese Patent For Its Lead Compound
Akelos Inc. Receives Chinese Patent For Its lead Compound NEW YORK, NY, UNITED STATES, January 29, 2025 / / -- Akelos Inc. Announces China Patent Office Allowance of Patent Claiming its Lead Compound Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti- hyperalgesic drug to treat chronic and neuropathic pain, announces that the China National Intellectual Property Administration (China's patent office) has allowed a patent application (No. 201980057151.1) with claims covering a number of compounds including its lead compound and its use to treat pain. The patent application covers inventions made at Weill Cornell Medicine by Peter Goldstein, MD, Professor of Anesthesiology, and his group. It is licensed exclusively to Akelos. This patent allowance is an important milestone for Akelos on its path towards commercialization of a new non-opioid painkiller that will alleviate suffering and help address the opioid epidemic. It follows the issuance of its US equivalent case, now US Patent No. 11,684,590 issued June 27, 2023, and the issuance of the Japanese equivalent. Patent applications are pending in the US, Europe, Canada, Australia and China, where further issuances are expected in the future. 'We are delighted to announce that the patent for our lead compound for the treatment of peripheral neuropathic pain, AKE-1018, has now been formally approved by the China Patent Office,' said Akelos Founder Dr. Steven Fox. 'This patent extends protection of our lead compound to China from the US and Japan. It will enable us to continue to develop this product, as well as next generation therapeutics. This news represents an important corporate achievement.' 'Formal approval by the patent offices of the US, Japan and China for our patent 'SUBSTITUTED ALKYLPHENOLS AS HCN1 ANTAGONISTS' is both the culmination of a significant effort by our entire team in the field of neuropathic pain therapeutics and it underpins our strategy to develop a novel drug delivery platform for other medical conditions beyond neuropathic pain,' said Dr. Goldstein, Akelos scientific co-founder and member of its Scientific Advisory Board who holds a financial interest in Akelos Inc. Akelos Inc. is dedicated to developing and commercializing a novel, non-opioid anti- hyperalgesic drug to treat chronic and neuropathic pain, and has entered into a research collaboration with Weill Cornell Medicine aimed at advancing the underlying science. For more information, please contact: Akelos Inc. Dr. Steven Fox, CEO 212-953-1544 [email protected] About Akelos Inc. Akelos Inc. is a biopharmaceutical clinical company focused on the translation of innovative science into treatment. The company currently is developing novel non- narcotic drugs for the treatment of neuropathic pain. The goal of Akelos is to address some of today's most pressing areas of unmet needs. Forward-Looking Statement Steven Fox Office of Dr. Steven Fox +1 212-953-1544
